By The Smartencyclopedia Staff
Introduction
Viruses are notorious for their ability to adapt and find innovative ways to navigate within the human body, challenging researchers to unravel their complex strategies. A recent study conducted by scientists at the Texas Biomedical Research Institute sheds light on a new method employed by the Ebola virus to infect cells. The findings, published in the Journal of Infectious Diseases, reveal that Ebola creates and utilizes intercellular tunnels, known as tunneling nanotubes, to hide and move within the host, evading conventional treatments.
Tunneling Nanotubes: Dynamic Connections Between Cells
Tunneling nanotubes are dynamic structures that serve as connections between cells, facilitating communication by allowing the exchange of particles over relatively long distances—up to 200 microns. While these structures have been implicated in various diseases such as neurodegenerative conditions, cancer, HIV-1, and influenza, this study is the first to explore their role in the dissemination of the Ebola virus.
Ebola’s Unconventional Spread Mechanism
The traditional model of Ebola virus spread involves the infection of a cell, replication, and the release of new virus particles to infect neighboring cells. However, the recent research challenges this simplistic view. Dr. Olena Shtanko, an Assistant Professor at Texas Biomed and the senior paper author, notes that their findings suggest the virus can create hiding places, move between cells, and replicate.
Insights from Advanced Imaging Technology
To investigate this phenomenon, the researchers employed state-of-the-art technology, including live scanning electron microscopy and high-resolution 3D microscopy. The results demonstrated that Ebola virus infection enhances the formation of tunneling nanotubes containing viral particles within cells. Remarkably, these nanotubes then facilitate the transfer of viral particles to adjacent cells.
Surprising Observations in the Presence of Treatments
One of the most surprising findings was that Ebola virus infection continued to spread in cultures treated with virus entry inhibitors or treatments designed to prevent viral entry into cells. This observation challenges the effectiveness of current treatment approaches and emphasizes the need for a deeper understanding of the virus’s spread mechanism.
Future Directions: Unraveling the Transport Mechanism
While the study provides crucial insights, several questions remain unanswered. The exact mechanism by which Ebola virus particles are transported through tunneling nanotubes remains a mystery. Dr. Shtanko and her team plan to utilize advanced technologies such as laser microdissection, mass spectrometry, and low-abundance RNA sequencing to delve into these intricate details.
Exploring Related Viruses and Animal Models
The researchers are not limiting their investigation to Ebola alone. They aim to explore whether related viruses, including the deadly Sudan and Marburg viruses, exploit similar mechanisms for infection spread. Collaborating with Texas Biomed Professor Ricardo Carrion, Jr., PhD, the team plans to analyze tissues from animal models to identify virus-containing nanotubes.
Funding and Conclusion
This groundbreaking research was made possible by grants from the National Institutes of Health National Institute of Allergy & Infectious Diseases and the Texas Biomedical Forum. Unraveling the secrets of Ebola’s stealth tactics opens new avenues for developing targeted therapies to combat the virus’s spread and offers hope in the ongoing battle against infectious diseases.
Story Source:
Materials provided by Texas Biomedical Research Institute. Note: Content may be edited for style and length.
Journal Reference:
- Marija A Djurkovic, Carson G Leavitt, Eusondia Arnett, Valeriia Kriachun, Luis Martínez-Sobrido, Rossella Titone, Laura J Sherwood, Andrew Hayhurst, Larry S Schlesinger, Olena Shtanko. Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination. The Journal of Infectious Diseases, 2023; 228 (Supplement_7): S522 DOI: 10.1093/infdis/jiad400